Chemo-immunotherapy with Dinutuximab Beta in Patients with Relapsed/progressive High-Risk Neuroblastoma: Does Chemotherapy Backbone Matter?
Patricia Raiser,Gudrun Schleiermacher,Marion Gambart,Benoit Dumont,Anne- Sophie Defachelles,Estelle Thebaud,Julie Tandonnet,Claudia Pasqualini,Stephanie Proust,Natacha Entz-Werle,Isabelle Aerts, Lee A. Ndounga-Diakou,Arnaud Petit,Chloe Puiseux, Camille Khanfar,Jeremie Rouger,Ludovic Mansuy,Joy Benadiba,Frederic Millot,Claire Pluchart,Salim Laghouati,Birgit Geoerger,Gilles Vassal,Dominique Valteau-Couanet,Pablo Berlanga EUROPEAN JOURNAL OF CANCER(2024)
AI 理解论文
溯源树
样例
